Revenue

3 Months Ended

Aug. 31, 2025

Revenue from Contract with Customer [Abstract]

Revenue

Note 6 – Revenue

Most of the Company’s revenue is generated by the performance of services to customers and recognized at a point in time based on the evaluation of when the customer obtains control of the products. Revenue is recognized when all performance obligations under the terms of a contract are satisfied, net of certain taxes and gain/loss resulting from changes in foreign currency. Revenue is recorded when customer acceptance is received and all performance obligations have been satisfied. Sales of goods typically do not include multiple products and/or service elements.

The table below summarizes the Company’s disaggregated revenue information:

	Quarter Ended August 31,
	2025		2024
Clinical trials	$	24,139	$	178,386
Consulting fees		–		–
Merchandise		61		501
Total revenue	$	24,200	$	178,887

Cost of revenue consists of third-party costs associated with patient stipends. At August 31, 2025, and August 31, 2024, cost of revenue was $8,143 and $8,362, respectively.